Medical Journals

Differential Structural Properties of Glp-1 and Exendin-4 Determine Their Relative Affinity for the Glp-1 Receptor N-terminal Extracellular Domain.

Authors:
  • Runge Steffen
  • Schimmer Susann
  • Oschmann Jan
  • Schiødt Christine Bruun
  • Knudsen Sanne Möller
  • Jeppesen Claus Bekker
  • Madsen Kjeld
  • Lau Jesper
  • Thøgersen Henning
  • Rudolph Rainer

From: Department of Structure and Biophysical Chemistry, Novo Nordisk, DK-2880 Bagsvaerd, Denmark. sffr@novonordisk.com

Biochemistry

  • Publish Date: May 2007
  • ISSN: 0006-2960
  • Volume: 46
  • Issue: 19
  • Pages: 5830-40
  • Medium: Print
  • Language: English
  • Citation (JAMA): Runge Steffen, Schimmer Susann, Oschmann Jan, et al. Differential Structural Properties of Glp-1 and Exendin-4 Determine Their Relative Affinity for the Glp-1 Receptor N-terminal Extracellular Domain.. Biochemistry May 2007;46:5830-40

Abstract

Glucagon-like peptide-1 (GLP-1) and exendin-4 (Ex4) are homologous peptides with established potential for treatment of type 2 diabetes. They bind and activate the pancreatic GLP-1 receptor (GLP-1R) with similar affinity and potency and thereby promote insulin secretion in a glucose-dependent manner. GLP-1R belongs to family B of the seven transmembrane G-protein coupled receptors. The N-terminal extracellular domain (nGLP-1R) is a ligand binding domain with differential affinity for Ex4 and GLP-1: low affinity for GLP-1 and high affinity for exendin-4. The superior affinity of nGLP-1R for Ex4 was previously explained by an additional interaction between nGLP-1R and the C-terminal Trp-cage of Ex4. In this study we have combined biophysical and pharmacological approaches thus relating structural properties of the ligands in solution to their relative binding affinity for nGLP-1R. We used both a tracer competition assay and ligand-induced thermal stabilization of nGLP-1R to measure the relative affinity of full length, truncated, and chimeric ligands for soluble refolded nGLP-1R. The ligands in solution and the conformational consequences of ligand binding to nGLP-1R were characterized by circular dichroism and fluorescence spectroscopy. We found a correlation between the helical content of the free ligands and their relative binding affinity for nGLP-1R, supporting the hypothesis that the ligands are helical at least in the segment that binds to nGLP-1R. The Trp-cage of Ex4 was not necessary to maintain a superior helicity of Ex4 compared to GLP-1. The results suggest that the differential affinity of nGLP-1R is explained almost entirely by divergent residues in the central part of the ligands: Leu10-Gly30 of Ex4 and Val16-Arg36 of GLP-1. In view of our results it appears that the Trp-cage plays only a minor role for the interaction between Ex4 and nGLP-1R and for the differential affinity of nGLP-1R for GLP-1 and Ex4.

Mesh Headings (Keywords): Amino Acid Sequence, Animals, Calorimetry, Differential Scanning, Circular Dichroism, Cricetinae, Glucagon-Like Peptide 1, Heat, Humans, Ligands, Molecular Sequence Data, Peptides, Protein Denaturation, Protein Folding, Protein Structure, Tertiary, Receptors, Glucagon, Sequence Alignment, Spectrometry, Fluorescence, Venoms


Check for Full Text / PubMed Unique Identifier (PMID): 17444618


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.